return to the homepage











Triple Negative Breast Cancer Day, 3.3.14, is the only national event solely devoted to raising both awareness of TNBC and funds that provide critical support for those affected by the disease.
Everyone is invited to participate. Click here.

Triple negative breast cancer (TNBC) is one of many forms of breast cancer.
Forms of breast cancer are generally diagnosed based on the presence or absence of three “receptors” known to fuel most breast cancer tumors: estrogen, progesterone and HER2-neu.
A diagnosis of TNBC means that the tumor in question is estrogenreceptor negative, progesterone-receptor negative and Her2-negative. In other words, triple negative breast cancer tumors do not exhibit any of the three known receptors.
Receptor-targeting therapies have fueled tremendous recent advances in the fight against breast cancer. Unfortunately, there is no such targeted therapy for triple negative breast cancer.
TNBC tends to be more aggressive, more likely to recur, and more difficult to treat because there is no targeted treatment.
TNBC disproportionately strikes younger women, women of African, Latina or Caribbean descent, and those with BRCA1 mutations.
Approximately every half hour, another woman in the US is diagnosed with triple negative breast cancer.


About the Triple Negative Breast Cancer Foundation (TNBCF)

Triple Negative Breast Cancer Foundation (TNBCF) was founded in 2006 in honor of Nancy Block-Zenna, who was diagnosed at the young age of 35 with triple negative breast cancer before succumbing to the disease in 2007. In response to Nancy’s diagnosis, her friends identified a dire need to create a central source of information for this dangerous and aggressive form of breast cancer, about which little was known just a short time ago. It is the Foundation’s mission to raise awareness of triple negative breast cancer and to support scientists and researchers in their effort to determine the disease’s definitive causes, so that effective detection, diagnosis, prevention and treatment can be pursued and achieved. TNBCF supports the triple negative breast cancer community in many ways:

We host regular “think tanks” which are attended by the top doctors and researchers in the field, to create roadmaps for a cure for triple negative breast cancer.
We offer research grant support to encourage the launch of projects aimed at finding targeted treatments for triple negative disease.
We co-sponsor a $6.4 million Promise Grant with Susan G. Komen for the Cure, which is aimed at finding targeted therapy for triple negative disease.
We offer a financial assistance program to help women with triple negative breast cancer afford transportation, child care and other expenses associated with their treatment.
We continuously expand our website, www.tnbcfoundation.org, and offer an ever-growing resources section and up-to-the-minute information about the disease.

TNBC Foundation® and Triple Negative Breast Cancer Foundation® are registered trademarks of Triple Negative Breast Cancer Foundation, Inc.
Homepage | © 2013 TNBC Foundation, Inc. | Disclaimer | Privacy Policy

Questions? Email us at info@tnbcfoundation.org or message us on Facebook or Twitter.